We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PSYBF market cap is 808.94k. The company's latest EPS is USD and P/E is N/A.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -52k | 0 | -19k | -6.52M | -2.69M |
| Net Income | -52k | -28k | -22k | -11.02M | -4.89M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Total Assets | 271k | 252k | 220k | 4.01M | 390k |
| Total Liabilities | 47k | 56k | 46k | 1.29M | 1.98M |
| Total Equity | 224k | 196k | 174k | 2.72M | -1.59M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Operating | -52k | -19k | -33k | -6.95M | -3.44M |
| Investing | N/A | N/A | N/A | -3.56M | 3.52M |
| Financing | -7k | N/A | N/A | 10.37M | -55k |
| Market Cap | 808.94k |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 132.61M |
| Average Volume (1 week) | 5.12k |
| Average Volume (1 Month) | 5.94k |
| 52 Week Change | -66.67% |
| 52 Week High | 0.027 |
| 52 Week Low | 0.003 |
| Spread (Intraday) | 0 (38.14%) |
| Company Name | Psybio Therapeutics Corporation (PK) |
| Address |
25th floor, 700 w georgia street vancouver, british columbia V7Y 1B3 |
| Website | https://www.psybiolife.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
